What happens after Adakveo's revocation in the EU? Understand the reasons for the EMA's decision, and the Adakveo alternatives you have.
Blog
-
October 03, 2023Read more »
-
September 27, 2023Read more »
Find out the key similarities and differences between Adakveo and Oxbryta, including how to access both medicines.
-
September 25, 2023Read more »
When will dostarlimab be available in Belgium? Find out all the ways to access it in the meantime.
-
September 25, 2023Read more »
When will dostarlimab be available in the UK? Learn everything worth knowing about accessing the medicine.
-
September 25, 2023Read more »
Why teclistamab isn't available in Germany (yet) and how to access it in the meantime.
-
September 13, 2023Read more »
What types of cancer can dostarlimab treat? See all the latest approvals and research about this novel cancer treatment.
-
September 04, 2023Read more »
A simple overview of Jemperli and Keytruda as treatment options for endometrial cancer. Find out how they work, how efficient they are, and how much they cost.
-
August 29, 2023Read more »
Is it possible to combine Dupixent with Opzelura in your eczema treatment? All your questioned answered.
-
August 29, 2023Read more »
Everything you and your doctor should know about the potential usage od Opzelura for psoriasis.
-
August 22, 2023Read more »
All vitiligo patients in the UK should know about Opzelura avaiability on the market, and the alternatives in the meantime.
-
August 22, 2023Read more »
Can you use Jakavi for your vitiligo, while waiting for Opzelura to become available on the European market? All you need to know.
-
August 22, 2023Read more »
Is it possible to get a Leqembi home infusion? Will you be able to inject Leqembi at home by yourself soon? Learn all we know.
-
August 03, 2023Read more »
The difference between Leqembi and Aduhelm, simply explained. How do these Alzheimer's medicines work, where are they approved, and how can you access them?
-
August 02, 2023Read more »
How nitisinone tablets give hope to HT-1 and AKU patients. Now also available for free in India, Pakistan, Bangladesh and Sudan.
-
July 14, 2023Read more »
Everything you need to know about Briumvi, the latest approved CD20 antibody for the treatment of multiple sclerosis.
-
June 26, 2023Read more »
All the safe and legal options to access Leqembi while it's waiting for its EU approval.
-
June 26, 2023Read more »
All you need to know about Leqembi, the latest approved Alzheimer's medicine.
-
June 16, 2023Read more »
Sotorasib vs Adagrasib: A side-by-side comparison of the latest Alzheimer's medicines.
-
Read more »
Anti-amyloid therapy for Alzheimer's, explained simply. What is it, how does it work, which one is approved, and how can you access it?
-
November 29, 2021Read more »
Paxlovid is an antiviral administered orally to patients who are ill with COVID-19 or have been exposed to the coronavirus SARS-CoV-2 and are at risk of developing severe illness. The manufacturer, pharmaceutical and biotechnology giant Pfizer, developed it to patients avoid severe illness which can lead to hospitalization and death. It is meant to be administered at the first sign of infection.
-
November 25, 2021Read more »
Molnupiravir is an orally administered antiviral medication that inhibits the replication of certain RNA viruses, and is used to treat COVID-19.
-
June 10, 2021Read more »
Aduhelm (aducanumab) is a monthly intravenous infusion intended to slow cognitive decline by reducing amyloid beta plaques in the brain.
-
January 26, 2021Read more »
Ubrelvy (ubrogepant) is a calcitonin gene-related peptide (CGRP) receptor antagonist indicated for the acute treatment of migraine headaches with or without aura.
-
January 22, 2021Read more »
Tukysa (tucatinib) is a medication used in combination with trastuzumab and capecitabine for the treatment of adult patients with advanced, unresectable or metastatic HER2-positive breast cancer.
-
Read more »
Radicut (edaravone) and Radicava (edaravone) is a medication for the treatment of patients with amyotrophic lateral sclerosis (ALS) and acute ischaemic stroke.
-
January 22, 2021Read more »
Trodelvy (sacituzumab govitecan-hziy) is an immune targeted therapy used for the 3rd line treatment of patients with metastatic triple-negative breast cancer (mTNBC).
-
January 21, 2021Read more »
Tagrisso (osimertinib) is a kinase inhibitor (targeted therapy) medication.
-
January 21, 2021Read more »
Vyndaqel (tafamidis) is a medicine indicated for the treatment of transthyretin amyloidosis in patients with stage 1 symptomatic polyneuropathy to delay peripheral neurologic impairment.
-
January 21, 2021Read more »
Tibsovo (ivosidenib) is an IDH1 inhibitor (targeted therapy) medication.
-
January 19, 2021Read more »
Enhertu (fam-trastuzumab deruxtecan-nxki) is an antibody-drug conjugate targeted therapy.
Recent Posts
